HP Stock Analysis: Helmerich Payne | NYSE
Oil & Gas Drilling | NYSE, USA | Market Cap: 3.979m USD | 12M Return: 65.8% | US4234521015 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 40.6M
Qual. Beats: -4
Rev. Trend: 89.2%
Qual. Beats: 1
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Helmerich & Payne, Inc. (HP) is a Tulsa, Oklahoma-based contract drilling company that provides drilling rigs, crews, and related technologies to oil and gas exploration and production (E&P) operators. Founded in 1920 and listed on the NYSE, it operates through three segments-North America Solutions (primarily Texas), Offshore Solutions (U.S. Gulf of Mexico, the North Sea, Norwegian Sea, and Caspian Sea), and International Solutions (Saudi Arabia, Argentina, Bahrain, Oman, Germany, and Kuwait). The company places a notable emphasis on developing and commercializing drilling technologies aimed at improving wellbore quality and placement. In addition to its core drilling business, H&P owns and operates a portfolio of commercial real estate assets, including a shopping center.
As a contract driller, HP sits within the oilfield services value chain and typically generates revenue by charging E&P operators a daily rate for the use of its rigs and crews, making its earnings closely tied to global oil and gas prices and the capital expenditure cycles of its customers. The industry is capital intensive, with rig fleets representing the largest deployed asset base and technology differentiation-such as automated and high-efficiency drilling systems-serving as a key competitive lever among large land drillers.
- US land rig count rises, boosting North America dayrates and utilization
- Saudi Aramco contract awards strengthen International Solutions backlog
- Capital returns accelerate through dividends and share buybacks
| Net Income: -137.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 4.48 > 1.0 |
| NWC/Revenue: 19.27% < 20% (prev 19.86%; Δ -0.59% < -1%) |
| CFO/TA 0.09 > 3% & CFO 579.6m > Net Income -137.4m |
| Net Debt (1.78b) to EBITDA (794.5m): 2.24 < 3 |
| Current Ratio: 1.96 > 1.5 & < 3 |
| Outstanding Shares: last quarter (100.0m) vs 12m ago 0.65% < -2% |
| Gross Margin: 10.49% > 18% (prev 19.40%; Δ -8.91% > 0.5%) |
| Asset Turnover: 60.78% > 50% (prev 49.96%; Δ 10.82% > 0%) |
| Interest Coverage Ratio: 0.60 > 6 (EBIT TTM 62.0m / Interest Expense TTM 103.8m) |
| A: 0.12 (Total Current Assets 1.57b - Total Current Liabilities 800.5m) / Total Assets 6.29b |
| B: 0.39 (Retained Earnings 2.46b / Total Assets 6.29b) |
| C: 0.01 (EBIT TTM 62.0m / Avg Total Assets 6.57b) |
| D: 0.71 (Book Value of Equity 2.57b / Total Liabilities 3.62b) |
| Altman-Z'' = 2.89 = A |
| DSRI: 0.95 (Receivables 869.5m/782.6m, Revenue 4.00b/3.43b) |
| GMI: 1.85 (GM 19.40% / 10.49%) |
| AQI: 0.96 (AQ_t 0.12 / AQ_t-1 0.12) |
| SGI: 1.17 (Revenue 4.00b / 3.43b) |
| TATA: -0.11 (NI -137.4m - CFO 579.6m) / TA 6.29b) |
| Beneish M = -2.21 (Cap -4..+1) = BB |
As of November 02, 2026, the stock is trading at USD 42.99 with a total of 2,338,203 shares traded. Over the past week, the price has changed by +10.37%, over one month by +17.43%, over three months by +28.02% and over the past year by +65.82%.
Current recommended Stop Loss: 39.70 (which is 7.7% or 2.1 ATR below the current price).
Helmerich Payne has received a consensus analysts rating of 3.53. Therefore, it is recommended to hold HP.
- StrongBuy: 4
- Buy: 4
- Hold: 7
- Sell: 1
- StrongSell: 1
| Analysts Target Price | 45.4 | 5.7% |
P/E Forward = 31.0559
P/S = 0.9956
P/B = 1.5122
P/EG = 5.7805
Revenue TTM = 4.00b USD
EBIT TTM = 62.0m USD
EBITDA TTM = 794.5m USD
Long Term Debt = 1.86b USD (from longTermDebt, last quarter)
Short Term Debt = 6.86m USD (from shortTermDebt, last quarter)
Debt = 2.01b USD (from shortLongTermDebtTotal, last quarter) + Leases 146.1m
Net Debt = 1.78b USD (calculated: Debt 2.01b - CCE 231.4m)
Enterprise Value = 5.76b USD (3.98b + Debt 2.01b - CCE 231.4m)
Interest Coverage Ratio = 0.60 (Ebit TTM 62.0m / Interest Expense TTM 103.8m)
EV/FCF = 18.25x (Enterprise Value 5.76b / FCF TTM 315.3m)
FCF Yield = 5.48% (FCF TTM 315.3m / Enterprise Value 5.76b)
FCF Margin = 7.89% (FCF TTM 315.3m / Revenue TTM 4.00b)
Net Margin = -3.44% (Net Income TTM -137.4m / Revenue TTM 4.00b)
Gross Margin = 10.49% ((Revenue TTM 4.00b - Cost of Revenue TTM 3.58b) / Revenue TTM)
Gross Margin QoQ = 12.03% (prev 7.04%)
Tobins Q-Ratio = 0.92 (Enterprise Value 5.76b / Total Assets 6.29b)
Interest Expense / Debt = 5.17% (Interest Expense 103.8m / Debt 2.01b)
Taxrate = 48.07% (72.4m / 150.5m)
NOPAT = 32.2m (EBIT 62.0m * (1 - 48.07%))
Current Ratio = 1.96 (Total Current Assets 1.57b / Total Current Liabilities 800.5m)
Debt / Equity = 0.78 (Debt 2.01b / totalStockholderEquity, last quarter 2.57b)
Debt / EBITDA = 2.24 (Net Debt 1.78b / EBITDA 794.5m)
Debt / FCF = 5.64 (Net Debt 1.78b / FCF TTM 315.3m)
Total Stockholder Equity = 2.61b (last 4 quarters mean from totalStockholderEquity)
RoA = -2.09% (Net Income -137.4m / Total Assets 6.29b)
RoE = -5.27% (Net Income TTM -137.4m / Total Stockholder Equity 2.61b)
RoCE = 1.39% (EBIT 62.0m / Capital Employed (Equity 2.61b + L.T.Debt 1.86b))
RoIC = 0.61% (NOPAT 32.2m / Invested Capital 5.29b)
WACC = 6.18% (E(3.98b)/V(5.99b) * Re(7.94%) + D(2.01b)/V(5.99b) * Rd(5.17%) * (1-Tc(0.48)))
Discount Rate = 7.94% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 89.02 | Cagr: 0.44%
[DCF] Terminal Value 77.97% ; FCFF base≈203.8m ; Y1≈233.6m ; Y5≈343.8m
[DCF] Fair Price = 33.99 (EV 5.17b - Net Debt 1.78b = Equity 3.40b / Shares 99.9m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -0.90 | # QB: -4
Revenue Correlation: 89.22 | Revenue CAGR: 18.09% | SUE: 1.78 | # QB: 1
EPS current Quarter (2026-12-31): EPS=0.29 | Chg30d=-8.29% | Revisions=+25% | Analysts=7
EPS current Year (2026-09-30): EPS=-0.39 | Chg30d=-138.23% | Revisions=+50% | GrowthEPS=-141.4% | GrowthRev=+8.4%
EPS next Year (2027-09-30): EPS=1.52 | Chg30d=+3.04% | Revisions=+17% | GrowthEPS=+491.0% | GrowthRev=+5.7%
[Analyst] Revisions Ratio: +50% (up=6, down=1)